platycodin D: triterpenoid saponin from a root of Platycodon grandiflorum; RN refers to (2beta,3beta,16alpha)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Platycodon | genus | A plant genus of the family CAMPANULACEAE that contains platycodin and other triterpenoid SAPONINS. It is a constituent of kikyo-to (MEDICINE, KAMPO).[MeSH] | Campanulaceae | A plant family of the order Campanulales, subclass Asteridae, class Magnoliopsida[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 162859 |
CHEMBL ID | 1641859 |
CHEBI ID | 70436 |
SCHEMBL ID | 23500390 |
MeSH ID | M0282892 |
Synonym |
---|
platycodin d |
C17410 |
58479-68-8 |
chebi:70436 , |
CHEMBL1641859 |
cwj06ta2gi , |
unii-cwj06ta2gi |
olean-12-en-28-oic acid, 3-(beta-d-glucopyranosyloxy)-2,16,23,24-tetrahydroxy-, o-d-apio-beta-d-furanosyl-(1-3)-o-beta-d-xylopyranosyl-(1-4)-o-6-deoxy-alpha-l-mannopyranosyl-(1-2)-l-arabinopyranosyl ester, (2beta,3beta,16alpha)- |
S9304 |
platycodin-d |
platycodin d [inci] |
singleex platycodin d 98 |
platycodind |
AC-34319 |
Q-100670 |
SCHEMBL23500390 |
mfcd09952590 |
AKOS037514784 |
Q15425261 |
BS-14123 |
HMS3887G11 |
CS-0016836 |
HY-N1411 |
CCG-270661 |
DTXSID901021773 |
Platycodin D (PD) is a triterpenoid saponin, extracted from the roots of the traditional Chinese herbal medicine Platycodon grandiflorum (Jacq.) A. It is effective against various human cancers, including glioblastoma multiforme (GBM)
Platycodin D (PLD) has been reported to have anti-inflammatory and anti-oxidant effects. It has been shown to fight cancer by inducing apoptosis, cell cycle arrest, and autophagy.
Excerpt | Reference | Relevance |
---|---|---|
"Platycodin D(PD) has a significantly inhibitory effect on multiple malignant tumors, and can inhibit the proliferation of leukemia cells K562 and induce apoptosis. " | ( [Inhibitory effect and mechanism of platycodin D combined with imatinib on K562/R]. Dai, Q; Ge, YQ, 2018) | 2.2 |
"Platycodin D has been reported to have anti-oxidant and anti-stress properties in various diseases." | ( Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats. Huang, D; Pei, C; Wang, F; Wang, X; Wang, Z; Wu, Y; Xiao, W, 2021) | 1.62 |
"Platycodin D (PLD) has been reported to have anti-inflammatory and anti-oxidant effects." | ( Platycodin D protects against cigarette smoke-induced lung inflammation in mice. Gao, W; Guo, Y; Yang, H, 2017) | 2.62 |
"Platycodin D(PD) has a significantly inhibitory effect on multiple malignant tumors, and can inhibit the proliferation of leukemia cells K562 and induce apoptosis. " | ( [Inhibitory effect and mechanism of platycodin D combined with imatinib on K562/R]. Dai, Q; Ge, YQ, 2018) | 2.2 |
"Platycodin D has been shown to fight cancer by inducing apoptosis, cell cycle arrest, and autophagy and inhibiting angiogenesis, invasion and metastasis by targeting multiple signalling pathways which are frequently deregulated in cancers suggesting that this multi-target activity rather than a single effect may play an important role in developing platycodin D into potential anti-cancer drug." | ( Killing cancer with platycodin D through multiple mechanisms. Khan, M; Ma, T; Maryam, A; Mehmood, T; Zhang, H, 2016) | 1.48 |
"Platycodin D (PD) has been reported to control obesity in vivo. " | ( Platycodin D inhibits lipogenesis through AMPKα-PPARγ2 in 3T3-L1 cells and modulates fat accumulation in obese mice. Kang, M; Kim, YS; Lee, EJ, 2012) | 3.26 |
Platycodin D promotes apoptosis in PTC cells. Could activate inhibitor of nuclear factor-kappaB kinase (IKK)-beta.
Excerpt | Reference | Relevance |
---|---|---|
"Platycodin D promotes apoptosis in PTC cells." | ( Platycodin D inhibits the malignant progression of papillary thyroid carcinoma by NF-κB and enhances the therapeutic efficacy of pembrolizumab. Deng, B; Sun, M, 2022) | 2.89 |
"Platycodin D could activate inhibitor of nuclear factor-kappaB kinase (IKK)-beta in the nuclear factor-kappaB (NF-kappaB) activation of upstream level, but not IKK-alpha." | ( Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes. Ahn, KS; Hahn, BS; Kim, YS; Kwack, K; Lee, EB, 2006) | 2.5 |
Platycodin D treatment significantly inhibited platelet aggregation in response to collagen, ADP, arachidonic acid and epinephrine. Treatment with platy codin D also resulted in a reduction of Peroxisome proliferator-activated receptor(PPAR)gamma expression.
Excerpt | Reference | Relevance |
---|---|---|
"Platycodin D treatment significantly inhibited platelet aggregation in response to collagen, ADP, arachidonic acid and epinephrine, reduced platelet P-selectin expression, integrin α" | ( Platycodin D inhibits platelet function and thrombus formation through inducing internalization of platelet glycoprotein receptors. Chen, C; Cheng, H; Ju, W; Li, X; Li, Z; Liu, Y; Luo, Q; Qi, K; Qiao, J; Sun, Z; Tang, K; Wei, G; Wu, X; Wu, Y; Xu, K; Xu, M; Yan, Z; Zeng, L; Zhu, F, 2018) | 3.37 |
"Treatment with platycodin D also resulted in a reduction of Peroxisome proliferator-activated receptor(PPAR)gamma expression and its binding to target DNA sequence." | ( Platycodin D inhibits adipogenesis of 3T3-L1 cells by modulating Kruppel-like factor 2 and peroxisome proliferator-activated receptor gamma. Chung, SI; Kang, R; Kim, YS; Lee, H; Yoon, Y, 2010) | 2.14 |
Excerpt | Reference | Relevance |
---|---|---|
"Cisplatin, a proven effective chemotherapeutic agent, has been used clinically to treat malignant solid tumors, whereas its clinical use is limited by serious side effect including nephrotoxicity." | ( Platycodin D suppresses cisplatin-induced cytotoxicity by suppressing ROS-mediated oxidative damage, apoptosis, and inflammation in HEK-293 cells. Hu, JN; Leng, J; Li, HP; Li, W; Li, XD; Liu, Y; Shen, Q; Wang, SH; Wang, YP; Wang, Z, 2021) | 2.06 |
Platycodin D has inhibitory effects of curcumenol or osthole on proliferation of 4T1 and MDA-MB-231 cells. In combination with Ophiopogon total saponins and each ingredient used alone (P<0.1)
Excerpt | Reference | Relevance |
---|---|---|
"To investigate the effects of platycodin D in combination with different active ingredients of Chinese herbs under different therapeutic principles on proliferation and invasion of 4T1 and MDA-MB-231 breast cancer cell lines." | ( [Effects of platycodin D in combination with different active ingredients of Chinese herbs on proliferation and invasion of 4T1 and MDA-MB-231 breast cancer cell lines]. Guo, BF; Han, XH; Liu, S; Ye, YY, 2012) | 1.05 |
"Verifying study showed that the inhibitory effects of platycodin D in combination with curcumenol or osthole on proliferation of 4T1 and MDA-MB-231 cells were better than those of platycodin D in combination with Ophiopogon total saponins and each ingredient used alone (P<0." | ( [Effects of platycodin D in combination with different active ingredients of Chinese herbs on proliferation and invasion of 4T1 and MDA-MB-231 breast cancer cell lines]. Guo, BF; Han, XH; Liu, S; Ye, YY, 2012) | 1.01 |
" To investigate the effect and mechanism of PD alone or combined with imatinib (IM) in inhibiting CML imatinib resistant cell line K562/R, the cell proliferation was examined by CCK8 assay to reveal the effect of PD on the inhibitory function of imatinib." | ( [Inhibitory effect and mechanism of platycodin D combined with imatinib on K562/R]. Dai, Q; Ge, YQ, 2018) | 0.76 |
Platycodi radix extract standardized to platycodin D inhibited angiogenesis in human volunteers, and paves the way for a dose-response study and a human clinical obesity trial.
Excerpt | Relevance | Reference |
---|---|---|
"Platycodi radix extract standardized to platycodin D inhibited angiogenesis in human volunteers, and paves the way for a dose-response study and a human clinical obesity trial." | ( Pharmacokinetic pilot study of the antiangiogenic activity of standardized platycodi radix. Gimble, J; Greenway, F; Liu, Z; Twiner, EM; Yu, Y, 2011) | 0.64 |
Role | Description |
---|---|
metabolite | Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
triterpenoid saponin | A terpene glycoside in which the terpene moiety is a triterpenoid. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID549976 | Antiproliferative activity against human HCT15 cells after 48 hrs by sulforhodamine B assay | 2010 | Journal of natural products, Nov-29, Volume: 73, Issue:11 | Antiproliferative effects of saponins from the roots of Platycodon grandiflorum on cultured human tumor cells. |
AID549977 | Antiproliferative activity against human MESSA cells after 48 hrs by sulforhodamine B assay | 2010 | Journal of natural products, Nov-29, Volume: 73, Issue:11 | Antiproliferative effects of saponins from the roots of Platycodon grandiflorum on cultured human tumor cells. |
AID549978 | Antiproliferative activity against human MESSA/DX5 cells after 48 hrs by sulforhodamine B assay | 2010 | Journal of natural products, Nov-29, Volume: 73, Issue:11 | Antiproliferative effects of saponins from the roots of Platycodon grandiflorum on cultured human tumor cells. |
AID549975 | Antiproliferative activity against human HCT15/CL02 cells after 48 hrs by sulforhodamine B assay | 2010 | Journal of natural products, Nov-29, Volume: 73, Issue:11 | Antiproliferative effects of saponins from the roots of Platycodon grandiflorum on cultured human tumor cells. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (1.41) | 18.2507 |
2000's | 22 (15.49) | 29.6817 |
2010's | 77 (54.23) | 24.3611 |
2020's | 41 (28.87) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (35.22) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (0.70%) | 5.53% |
Reviews | 5 (3.50%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 137 (95.80%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |